With hundreds of vaccines currently in research and development worldwide, vaccines are among the fastest growing segments of the biopharmaceutical market today. The renewed investment in vaccine development has been accompanied by formidable challenges - both for biopharmaceutical research companies pursuing the next generation of products, as well as the clinical supply chain industry, to which responsibility for packaging, labelling, storing and delivering vaccines for global clinical trials has been outsourced.

In addition to their cost and complexity to develop and manufacture, vaccines must be stored, transported and maintained at controlled temperatures in a 'cold chain', a strict system of temperature and stock control to ensure their potency and safety.

Download this free white paper from Fisher Clinical Services to find out more.